Abstract
techniques. The first patient examined by whole-body NMRimaging had carcinoma ofthe oesophagus diagnosed on barium meal examination. A technetium-99msulphur colloid liver scan also showed hepatic metastases.
NMR imaging showed a large tumour in the lower third of the oesophagus, and areas of increased proton spinlattice relaxation time (T1) on a section through the liver corresponded with the metastases shown on the radionuclide
scan. Increased areas of T1 were present in some vertebrae, and a technetium-99m bone scan confirmed the presence of bone metastases.The NMR images in this patient compared well withthe images from other techniques. The continuing clinical trial may show that NMR is an accurate diagnostic aid which will complement existing techniques for diagnosing intrathoracic and intra-abdominal conditions.
| Original language | English |
|---|---|
| Pages (from-to) | 510-512 |
| Number of pages | 3 |
| Journal | BMJ Rapid Response |
| Volume | 282 |
| Issue number | 6263 |
| DOIs | |
| Publication status | Published - 1981 |
Cite this
Esophageal-Carcinoma Demonstrated by Whole-Body Nuclear Magnetcic-Resonance Imaging. / Smith, Francis; Hutchison, James McDonald Strachan; MALLARD, J R ; Johnson, G; Redpath, Thomas William; Selbie, R.d.; Smith, C C; Reid, Anne .
In: BMJ Rapid Response, Vol. 282, No. 6263, 1981, p. 510-512.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Esophageal-Carcinoma Demonstrated by Whole-Body Nuclear Magnetcic-Resonance Imaging
AU - Smith, Francis
AU - Hutchison, James McDonald Strachan
AU - MALLARD, J R
AU - Johnson, G
AU - Redpath, Thomas William
AU - Selbie, R.d.
AU - Smith, C C
AU - Reid, Anne
PY - 1981
Y1 - 1981
N2 - The quality of the images produced by nuclear magnetic resonance (NMR) imaging has steadily improved over the past five years. Images of the head, thorax, and abdomen have clearly shown the normal anatomy. A clinical trial ofNMR imaging has therefore been started in Aberdeen to assess its diagnostic accuracy and compare it with conventional radiography and other imaging techniques. The first patient examined by whole-body NMRimaging had carcinoma ofthe oesophagus diagnosed on barium meal examination. A technetium-99msulphur colloid liver scan also showed hepatic metastases. NMR imaging showed a large tumour in the lower third of the oesophagus, and areas of increased proton spinlattice relaxation time (T1) on a section through the liver corresponded with the metastases shown on the radionuclide scan. Increased areas of T1 were present in some vertebrae, and a technetium-99m bone scan confirmed the presence of bone metastases.The NMR images in this patient compared well withthe images from other techniques. The continuing clinical trial may show that NMR is an accurate diagnostic aid which will complement existing techniques for diagnosing intrathoracic and intra-abdominal conditions.
AB - The quality of the images produced by nuclear magnetic resonance (NMR) imaging has steadily improved over the past five years. Images of the head, thorax, and abdomen have clearly shown the normal anatomy. A clinical trial ofNMR imaging has therefore been started in Aberdeen to assess its diagnostic accuracy and compare it with conventional radiography and other imaging techniques. The first patient examined by whole-body NMRimaging had carcinoma ofthe oesophagus diagnosed on barium meal examination. A technetium-99msulphur colloid liver scan also showed hepatic metastases. NMR imaging showed a large tumour in the lower third of the oesophagus, and areas of increased proton spinlattice relaxation time (T1) on a section through the liver corresponded with the metastases shown on the radionuclide scan. Increased areas of T1 were present in some vertebrae, and a technetium-99m bone scan confirmed the presence of bone metastases.The NMR images in this patient compared well withthe images from other techniques. The continuing clinical trial may show that NMR is an accurate diagnostic aid which will complement existing techniques for diagnosing intrathoracic and intra-abdominal conditions.
U2 - 10.1136/bmj.282.6263.510
DO - 10.1136/bmj.282.6263.510
M3 - Article
VL - 282
SP - 510
EP - 512
JO - BMJ
JF - BMJ
SN - 0959-8146
IS - 6263
ER -